We are live on ! Find out more
RCM

Riverhead Capital Management Portfolio holdings

AUM $2.71B
1-Year Est. Return 2.34%
This Fund
S&P 500
This Quarter Est. Return
+1.42%
1 Year Est. Return
+2.34%
3 Year Est. Return
+45.7%
5 Year Est. Return
+71.11%
10 Year Est. Return
–
AUM
$2.71B
AUM Growth
-$3.34M
Cap. Flow
-$19.3M
Cap. Flow %
-0.71%
Top 10 Hldgs %
12.6%
Holding
1,579
New
62
Increased
514
Reduced
352
Closed
83

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$20.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$9.12M
3
MSFT icon
Microsoft
MSFT
+$7.23M
4
T icon
AT&T
T
+$6.88M
5
C icon
Citigroup
C
+$6.4M

Top Sells

Rank Stock Value
1
MET icon
MetLife
MET
+$7.59M
2
RHI icon
Robert Half
RHI
+$7.08M
3
FTNT icon
Fortinet
FTNT
+$6.33M
4
ALLY icon
Ally Financial
ALLY
+$5.86M
5
FFIV icon
F5
FFIV
+$4.64M

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Financials 14.81%
3 Healthcare 13.01%
4 Industrials 10.94%
5 Consumer Discretionary 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
1476
DELISTED
Esperion Therapeutics
ESPR
$14K ﹤0.01%
375
– –
ZGNX
1477
DELISTED
Zogenix, Inc.
ZGNX
$14K ﹤0.01%
343
+136
+66% +$6.27K
ACGL icon
1478
Arch Capital
ACGL
$35.1B
$13K ﹤0.01%
300
-8,500
-97% -$335K
HEI icon
1479
HEICO Corp
HEI
$47.6B
$13K ﹤0.01%
+100
New +$13.7K
ARGX icon
1480
argenx
ARGX
$54.7B
$12K ﹤0.01%
102
– –
ASND icon
1481
Ascendis Pharma A/S
ASND
$16.7B
$12K ﹤0.01%
127
– –
GWPH
1482
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$12K ﹤0.01%
107
– –
AMRN
1483
Amarin Corp
AMRN
$292M
$11K ﹤0.01%
37
– –
AWI icon
1484
Armstrong World Industries
AWI
$6.46B
$10K ﹤0.01%
100
-8,950
-99% -$862K
BPMC
1485
DELISTED
Blueprint Medicines
BPMC
$10K ﹤0.01%
136
– –
DXPE icon
1486
DXP Enterprises
DXPE
$2.7B
$10K ﹤0.01%
+300
New +$10.1K
KRTX
1487
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$10K ﹤0.01%
642
– –
VCIT icon
1488
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.4B
$9K ﹤0.01%
100
– –
ICL icon
1489
ICL Group
ICL
$6.78B
$8K ﹤0.01%
1,765
– –
TW icon
1490
Tradeweb Markets
TW
$20.7B
$8K ﹤0.01%
223
-75
-25% -$3.31K
EZPW icon
1491
Ezcorp Inc
EZPW
$2B
$7K ﹤0.01%
+1,100
New +$9.42K
ITRM
1492
DELISTED
Iterum Therapeutics
ITRM
$7K ﹤0.01%
78
– –
MORF
1493
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$7K ﹤0.01%
407
– –
GBT
1494
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7K ﹤0.01%
149
– –
ANGI icon
1495
Angi Inc
ANGI
$243M
– –
-226
Closed -$29K
ARMK icon
1496
Aramark
ARMK
$14.8B
– –
-13,951
Closed -$363K
ATRA icon
1497
Atara Biotherapeutics
ATRA
$77.8M
– –
-10
Closed -$5K
BABA icon
1498
Alibaba
BABA
$283B
– –
-3,185
Closed -$540K
BAH icon
1499
Booz Allen Hamilton
BAH
$7.66B
– –
-25,352
Closed -$1.68M
BGC icon
1500
BGC Group
BGC
$5.44B
– –
-5,337
Closed -$28K
58 59
60
61 62

Similar funds

TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return

Riverhead Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Riverhead Capital Management held 1,579 positions worth $2.71B, down 0.12% from $2.71B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Riverhead Capital Management's Q3 2019 filing shows 62 new, 514 increased, 352 reduced and 83 closed positions. Its largest new stake was iShares Russell 2000 ETF: 132,000 shares worth $20M. The largest sale was MetLife, an estimated $7.59M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Riverhead Capital Management's largest Q3 2019 buy was iShares Russell 2000 ETF: 132,000 shares worth $20M.
  • Riverhead Capital Management added most to Johnson & Johnson in Q3 2019, an estimated $9.12M increase.
  • Riverhead Capital Management's biggest Q3 2019 reduction was MetLife, cutting an estimated $7.59M.
  • Riverhead Capital Management fully exited Booz Allen Hamilton in Q3 2019, selling an estimated $1.68M.
  • Riverhead Capital Management's ten largest holdings make up 13% of its $2.71B portfolio in Q3 2019.
  • Riverhead Capital Management opened 62 new positions and closed 83 in Q3 2019.
  • Riverhead Capital Management's portfolio value fell 0.12% quarter-over-quarter to $2.71B.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.